Antineoplaston Therapy in Treating Patients With Neurofibroma and Schwannoma

Summary

RATIONALE: Current therapies for adults with a recurrent/residual Neurofibroma or Schwannoma provide limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the treatment of adults with a recurrent/residual Neurofibroma or Schwannoma. PURPOSE: This study is being performed to determine the effects (good and bad) that Antineoplaston therapy has on adults with a recurrent/residual Neurofibroma or Schwannoma.

Timeline

Start

1999-03

Primary completion

2001-08

Completion

2001-08

Drugs

Indications